Stop this barbaric experiment

2012-05-14 00:00

AROUND 700 000 people die every year from malaria. Most of these are children in Africa. Although some progress has been made, this disease remains a serious global health problem. While most people understand that malaria is transmitted by mosquitoes and can be controlled and cured, the battle against it is complex and difficult. And increasingly clear is that anti-insecticide activism by environmentalist groups is seriously undermining the fight.

The fight against malaria relies on two main interventions — controlling mosquitoes with insecticides, and treating patients with malaria medicines. Both these interventions face the problem of resistance, either by the mosquito against the insecticide or the malaria parasite against the medicine. Thanks to advocacy, public policies and commitments from the pharmaceutical industry, progress has been made in keeping slightly ahead of parasite resistance and ensuring access to effective medicines. Regrettably the same cannot be said for insecticides.

Only four classes of insecticide are approved by the World Health Organisation (WHO) for public health purposes. Within these classes, only 12 insecticides are available for indoor residual spraying (IRS). Although it may seem there is sufficient variation among these alternatives, not all are always suitable and their costs vary enormously. For cash-strapped African countries and donor agencies with shrinking budgets, small variations in cost could significantly affect malaria control with devastating consequences.

Pyrethroids are used extensively in agriculture and are also the only approved class of insecticide used to treat bed nets. With the growing resistance among this class, countries could be compelled to use alternative and far more costly insecticides that do not suffer from widespread resistance.

With the exception of DDT, all other WHO-approved insecticides are reformulated agricultural insecticides that were adapted for public health purposes. The reason for this is simple: the public health insecticide market comprises approximately one percent of the total. There is thus very little economic incentive to develop alternative insecticides that are specifically formulated for the public health market. Yet research and development for new insecticides for malaria control as well as other public health applications, is crucial.

For decades, well-funded and effective environmental campaigns have stigmatised insecticides, even though they are as essential for public health as medicines or vaccines. Regulatory costs of developing new insecticides have risen sharply, destroying what limited financial incentives remain. Anti-insecticide activists still push for alternative control interventions such as removing standing water, planting alleged mosquito-repelling trees, and using fish to eat mosquito larvae, even though none of these interventions has been shown to work effectively.

Recently, my colleague Richard Tren, with Michael Miller of the Duke Global Health Institute at Duke University, published a paper in the journal Research and Reports in Tropical Medicine. They estimate: “Short of a dramatic increase in funding to cover the higher cost of new insecticides, indoor spraying coverage rates in some African countries could fall dramatically, by between 40 and 50%.” In just seven sample countries examined, the number of people who could lose protection due to higher insecticide costs could be as high as 4,7 million annually.

Tren and Miller proposed several low-cost or no-cost options for policymakers to consider, all of which already exist to increase access to essential HIV/Aids and malaria drugs. For instance, they propose new pricing models that would ensure ongoing access to insecticides for poor countries, while protecting home country markets. They also propose incentives for new public health insecticide research, such as easing the regulatory burden on profitable agricultural and horticultural products in return for investment in public health products.

For the millions of poor people worldwide who are exposed to infected mosquitoes, insecticides used to kill the insects mean the difference between life and death. The idea that malaria-control program­mes can operate effectively without the use of insecticides is barbaric and amounts to a cruel experiment being carried out on malaria sufferers. The anti-insecticide agenda has cost lives and hampers malaria control programmes. It should be stopped.

• Jasson Urbach is a director of the Health Policy Unit and Africa Fighting Malaria.

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Comments have been closed for this article.

Inside News24

 
/News

Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.
 
English
Afrikaans
isiZulu

Hello 

Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.


Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Settings

Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.




Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.